FDA Peptide Update: Category 2 Removals Explained FDA considers adding a dozen peptides to its bulk drug compounding list RAPS When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction